Edward Kim, MD
Surgery · Raleigh, NCNPI 1376614438
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,980 of the $20,440 with a category attached, or 68.4%. Covidien LP accounts for 67.2% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $8,443 and has fallen 88.1% since, to $1,001 in 2025. Among surgery clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 61 payments — averaging $335.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$14K
- Intuitive Surgical$3K
- Davol Inc.$1K
- Alk-abello, Inc$900
- Musculoskeletal Transplant Foundation Inc.$591
- Johnson & Johnson$401
- plus $1K from 13 others
Across 13 payments — averaging $2979.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$38K
- Novartis$491
What the payments were for
- Consulting fees$13,98068%
- Speaking & faculty fees$5002%
- Travel & lodging$1,2426%
- Food & beverage$3,71818%
- Education$1,0005%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 12 | $13,737 |
| Intuitive Surgical | 14 | $2,647 |
| Davol Inc. | 12 | $1,043 |
| Alk-abello, Inc | 1 | $900 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $591 |
| Johnson & Johnson(2 entities) | 5 | $401 |
| W. L. Gore & Associates, Inc. | 1 | $188 |
| TELA Bio, Inc. | 2 | $167 |
| Boston Scientific | 2 | $162 |
| Stryker | 2 | $141 |
| Abbott | 1 | $122 |
| Acell, Inc. | 1 | $97 |
| Medtronic | 1 | $97 |
| Checkpoint Surgical, Inc | 1 | $56 |
| Conmed Corporation | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $19 |
| Baxter Healthcare | 1 | $18 |
| Endogastric Solutions, Inc | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,440 in reported general payments places this provider in the 90th percentile of 970 surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 143 | $431 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 113 | $262 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $67 |
| Oxycodone Hcl | 13 | $25 |
| Tramadol Hcl | 17 | $16 |
Paid to pharmacies, not to this prescriber.
Other surgery in Raleigh
- Martyn KnowlesRaleigh$311K
- Peter NgRaleigh$268K
- Alan KypsonRaleigh$44K
- Brant HenifordCharlotte$831K
- Vedra AugensteinCharlotte$789K
- John MartinieCharlotte$712K
- Dana PortenierDurham$702K
- Paul EnochsCary$595K
- David IannittiCharlotte$360K
- William HopeWilmington$350K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.